Involvement of ABC transporters in melanogenesis and the development of multidrug resistance of melanoma
Open Access
- 14 October 2009
- journal article
- review article
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 22 (6) , 740-749
Abstract
Summary: Because melanomas are intrinsically resistant to conventional radiotherapy and chemotherapy, many alternative treatment approaches have been developed such as biochemotherapy and immunotherapy. The most common cause of multidrug resistance (MDR) in human cancers is the expression and function of one or more ATP‐binding cassette (ABC) transporters that efflux anticancer drugs from cells. Melanoma cells express a group of ABC transporters (such as ABCA9, ABCB1, ABCB5, ABCB8, ABCC1, ABCC2, and ABCD1) that may be associated with the resistance of melanoma cells to a broad range of anticancer drugs and/or of melanocytes to toxic melanin intermediates and metabolites. In this review, we propose a model (termed the ABC‐M model) in which the intrinsic MDR of melanoma cells is at least in part because of the transporter systems that may also play a critical role in reducing the cytotoxicity of the melanogenic pathway in melanocytes. The ABC‐M model suggests molecular strategies to reverse MDR function in the context of the melanogenic pathway, which could open therapeutic avenues towards the ultimate goal of circumventing clinical MDR in patients with melanoma.Keywords
This publication has 62 references indexed in Scilit:
- Influence of Melanosome Dynamics on Melanoma Drug SensitivityJNCI: Journal of the National Cancer Institute, 2009
- Adoptive cell therapy for the treatment of patients with metastatic melanomaCurrent Opinion in Immunology, 2009
- Efficient tumour formation by single human melanoma cellsNature, 2008
- Identification of cells initiating human melanomasNature, 2008
- Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomasProceedings of the National Academy of Sciences, 2006
- Targeting multidrug resistance in cancerNature Reviews Drug Discovery, 2006
- A Tumorigenic Subpopulation with Stem Cell Properties in MelanomasCancer Research, 2005
- Apoptosis and melanoma chemoresistanceOncogene, 2003
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- Tyrosinase-related protein 2 as a mediator of melanoma specific resistance to cis-diamminedichloroplatinum(II): therapeutic implicationsOncogene, 2000